Search
Sort Results
Filter by Specific Population
- Women (remove)
Filter by Topic
Filter by Infection
Filter by Resource Category
Search results
Current filters: Treatment, Reproductive and maternal health, Women
10 search results
- Decreasing the risk of neural tube defects with dolutegravir
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - FDA warns that Prezcobix should not be used by HIV-positive pregnant women
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - Agencies issue caution about use of dolutegravir by pregnant HIV-positive women
-
2018, CATIE
Research summary - Webpage - Quebec study is reassuring about the safety of HIV treatment during pregnancy
-
2017, CATIE
Research summary - Webpage - Canadian researchers review the use of raltegravir in pregnancy
-
2016, CATIE
Research summary - Webpage - U.S. study reviews use and impact of integrase inhibitors in pregnancy
-
2016, CATIE
Research summary - Webpage - A successful pregnancy and birth outcome with dolutegravir-based ART
-
From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage - Dolutegravir—Interaction with atazanavir during pregnancy
-
From TreatmentUpdate 212
2016, CATIE
Research summary - Webpage - Premature births, protease inhibitors and progesterone
-
From TreatmentUpdate 206
2015, CATIE
Research summary - Webpage - 8. Menstrual Changes
-
From A Practical Guide to HIV Drug Side Effects
2013, CATIE
Client resources - Webpage
